|

FL115+PD-1 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • Suzhou Forlong Biotechnology Co., Ltd1

Indications

  • Advanced Solid Tumors1
  • Cancer1

Other1 trial

A Study of FL115 in Combination With a PD-1 Antibody in Advanced Solid Tumors
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.